UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007864
Receipt number R000009266
Scientific Title Evaluation of the effect of single-shot high dosed antithrombin in deceased donor kidney transplantation on ischemia/reperfusion injury and safety in a single center controlled randomized trial
Date of disclosure of the study information 2012/04/30
Last modified on 2012/04/30 00:01:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effect of single-shot high dosed antithrombin in deceased donor kidney transplantation on ischemia/reperfusion injury and safety in a single center controlled randomized trial

Acronym

Antithrombin in kidney transplantation

Scientific Title

Evaluation of the effect of single-shot high dosed antithrombin in deceased donor kidney transplantation on ischemia/reperfusion injury and safety in a single center controlled randomized trial

Scientific Title:Acronym

Antithrombin in kidney transplantation

Region

Europe


Condition

Condition

End-stage renal failure

Classification by specialty

Nephrology Surgery in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the hypothesis that intraoperative high-dose AT administration can reduce I/R-injury in clinical deceased-donor kidney transplantation and can be applied safely in the clinical setting

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

primary efficacy variable: degree of graft I/R-injury

Key secondary outcomes

secondary efficacy variable: transplant kidney function; tertiary efficacy variable:12-month graft/patient survival; safety variables relevant to intraoperative AT usage.: incidence of systemic anaphylaxis, incidence of bleeding events, number of units of packed red blood cells administered up to postoperative day 3, incidence of wound complications, and re-operations.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

treatment group: intraoperative administration via central venous line of a single-dose of 4,000 IU of AT (Atenativ, Octapharma, Langenfeld, Germany) at the beginning of the renal vein anastomosis, AT administration completeted by the time of reperfusion.

Interventions/Control_2

control group: corresponding dose of human albumin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

informed consent, age >18 years, undergoing deceased donor kidney transplantation

Key exclusion criteria

ongoing medication with anticoagulant drugs with the exception of acetylsalicylic acid, positive history of bleeding/procoagulant disorders (hereditary AT-deficiency, factor-V-Leiden mutation, prothrombin mutation, antiphospholipid syndromes, deficiency of protein C or protein&#160;S)

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Johannes N. Hoffmann, MD

Organization

Ludwig-Maximilians-University Munich, Germany

Division name

Campus Grosshadern, Dpt. of surgery

Zip code


Address

Marchioninistr. 15, 81377 Munich, Germany

TEL

498970950

Email



Public contact

Name of contact person

1st name
Middle name
Last name Jan M. Fertmann, MD

Organization

Ludwig-Maximilians-University Munich, Germany

Division name

Campus Grosshadern, Dpt. of surgery

Zip code


Address

Marchioninistr. 15, 81377 Munich, Germany

TEL

498970950

Homepage URL

http://www.klinikum.uni-muenchen.de/Chirurgische-Klinik-und-Poliklinik-Grosshadern/de/index.html

Email

jan.fertmann@med.uni-muenchen.de


Sponsor or person

Institute

Ludwig-Maximilians-University Munich, Germany

Institute

Department

Personal name



Funding Source

Organization

Study is in part funded by Octapharma (Langenfeld, Germany)

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

Germany


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

University Hospital of Ludwig-Maximilians-University, Campus Grosshadern, Munich, Germany


Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2001 Year 06 Month 15 Day

Date of IRB


Anticipated trial start date

2001 Year 09 Month 01 Day

Last follow-up date

2004 Year 04 Month 01 Day

Date of closure to data entry

2005 Year 08 Month 01 Day

Date trial data considered complete

2005 Year 08 Month 01 Day

Date analysis concluded

2006 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 04 Month 30 Day

Last modified on

2012 Year 04 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009266


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name